These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21294215)

  • 1. Multiple levels of PKR inhibition during HIV-1 replication.
    Clerzius G; Gélinas JF; Gatignol A
    Rev Med Virol; 2011 Jan; 21(1):42-53. PubMed ID: 21294215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.
    Ong CL; Thorpe JC; Gorry PR; Bannwarth S; Jaworowski A; Howard JL; Chung S; Campbell S; Christensen HS; Clerzius G; Mouland AJ; Gatignol A; Purcell DF
    J Virol; 2005 Oct; 79(20):12763-72. PubMed ID: 16188979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
    Li S; Min JY; Krug RM; Sen GC
    Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 translation and its regulation by cellular factors PKR and PACT.
    Burugu S; Daher A; Meurs EF; Gatignol A
    Virus Res; 2014 Nov; 193():65-77. PubMed ID: 25064266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication.
    Clerzius G; Shaw E; Daher A; Burugu S; Gélinas JF; Ear T; Sinck L; Routy JP; Mouland AJ; Patel RC; Gatignol A
    Retrovirology; 2013 Sep; 10():96. PubMed ID: 24020926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms.
    Cai R; Carpick B; Chun RF; Jeang KT; Williams BR
    Arch Biochem Biophys; 2000 Jan; 373(2):361-7. PubMed ID: 10620360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation.
    Singh M; Castillo D; Patel CV; Patel RC
    Biochemistry; 2011 May; 50(21):4550-60. PubMed ID: 21526770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
    Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
    J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.
    Sanghvi VR; Steel LF
    J Virol; 2011 Dec; 85(23):12614-21. PubMed ID: 21937648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 and PACT contribute to efficient translation of transcripts containing HIV-1 trans-activating response (TAR) element.
    Chukwurah E; Handy I; Patel RC
    Biochem J; 2017 Mar; 474(7):1241-1257. PubMed ID: 28167698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.
    Clerzius G; Gélinas JF; Daher A; Bonnet M; Meurs EF; Gatignol A
    J Virol; 2009 Oct; 83(19):10119-28. PubMed ID: 19605474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
    Min JY; Li S; Sen GC; Krug RM
    Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA binding and modulation of PKR activity.
    Gunnery S; Mathews MB
    Methods; 1998 Jul; 15(3):189-98. PubMed ID: 9735304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.
    Yoon CH; Kim SY; Byeon SE; Jeong Y; Lee J; Kim KP; Park J; Bae YS
    J Virol; 2015 Apr; 89(8):4262-80. PubMed ID: 25653431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of unphosphorylated form of human double-stranded RNA-activated protein kinase in Escherichia coli.
    Matsui T; Tanihara K; Date T
    Biochem Biophys Res Commun; 2001 Jun; 284(3):798-807. PubMed ID: 11396973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.
    McKenna SA; Kim I; Liu CW; Puglisi JD
    J Mol Biol; 2006 May; 358(5):1270-85. PubMed ID: 16580685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.
    Ventoso I; Sanz MA; Molina S; Berlanga JJ; Carrasco L; Esteban M
    Genes Dev; 2006 Jan; 20(1):87-100. PubMed ID: 16391235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.